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Background: Exposure to persistent engineered nano and micro particles via the oral route is well established. Animal
studies have demonstrated that, once ingested, a small proportion of such particles translocate from the gastrointestinal
tract to other tissues. Exposure to titanium dioxide is widespread via the oral route, but only one study has provided
indirect evidence (total titanium analyses) of absorption into the blood stream in humans. We sought to replicate these
observations and to provide additional evidence for particulate uptake.
Findings: Human volunteers with normal intestinal permeability were orally administered 100 mg pharmaceutical/food
grade titanium dioxide. Blood samples were collected from 0.5 to 10 h post ingestion and analysed for the presence of
reflectant bodies (particles) by dark field microscopy, and for total titanium by inductively coupled plasma mass
spectrometry (ICP-MS). Blood film analyses implied early absorption of particles (2 h) with a peak maximum at 6 h
following ingestion. The presence of these reflectant particles in blood roughly mirrored the levels of total titanium by
ICP-MS, providing good evidence for the latter being a measure of whole particle (titanium dioxide) absorption.
Conclusions: This study shows that a fraction of pharmaceutical/food grade titanium dioxide is absorbed systemically by
humans following ingestion. It confirms that at least two routes of particle uptake may exist in the human gut- one
proximal and one distal. Further work should quantify human exposure and uptake of such persistent particles.
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Oral exposure to non-biological nano- and micro- parti-
cles from the diet, environment, and man-made health
and hygiene products, is now well established [1].
Persistent particles, meaning those that are not broken
down easily by the gastrointestinal tract or intracellularly,
have been the subject of particular attention as animal
studies indicate that they may migrate from the gut
mucosa to draining lymph nodes and then become trans-
located to most tissues of the body [2]. However, there is
much less evidence in man. Examination of surgical and
post-mortem specimens has confirmed that there is
retention of engineered particles in the human intestinal* Correspondence: jonathan.powell@mrc-hnr.cam.ac.uk
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[3–5]. Using large micron-sized biological particles (such
as starch and pollen), Volkeimer has convincingly shown
their appearance in the blood stream following ingestion
by humans. With histological studies in rodents he
developed the concept of ‘persorption’ whereby holes in
the tips of intestinal villi allow the ingress of particles
[6, 7]. This and other mechanisms of uptake by the gut
have been studied and reviewed by us [1] and others
[8, 9]. Oral absorption of particulate titanium dioxide
(TiO2), a common food additive and excipient used in
nutraceuticals, pharmaceuticals and toothpaste [10],
has been especially well studied in animals [11], but
barely so in man. To date, only Bockmann et al. have
shown in humans that measurable increases in total
titanium (Ti) levels occur in the blood stream following
ingestion of capsules containing TiO2 particles [12]. Givendistributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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mulates in human intestinal cells [3–5], it is probable that
Bockmann et al. were showing direct particle uptake, al-
though this was not measured. Despite high interest on
the use of TiO2 particles and their potential impact fol-
lowing acute and chronic exposure, investigative studies
looking at TiO2 absorption in humans have only been re-
ported once, in 2015 [13], since the initial published find-
ings in the year 2000 [12]. However, in the recent work,
high baseline values appear to have prevented observations
on the appearance of Ti in the circulation following inges-
tion of TiO2 [13]. Here, in a simple pilot study that used
pharmaceutical and food grade anatase TiO2 particles, we
sought to corroborate the earlier findings of Bockmann et
al. and, further, to confirm that the increased levels of Ti
observed in blood are due to whole particle uptake into
the circulation. As single particle analysis was not fully
developed for quantitative analysis of blood samples,
we chose to use a simple semi-quantitative method for
particle detection, namely dark field microscopy. TiO2
readily reflects light so particles can easily be detected
in complex biological samples using this technique
[14]. A 100 mg TiO2 oral dose was chosen as this is to be
at the upper end of the normal daily intake of engineered
particles by humans [10], and the sampling intervals were
similar to those of Bockmann et al. (i.e. between 0–10 h).
We additionally determined whether blood Ti levels mir-
rored the presence of reflectant particles in blood as
together they should provide unambiguous evidence of
TiO2 particle absorption.
Methods
Preparation of permeability solution and TiO2 capsules
To assess that the volunteers had normal intestinal perme-
ability, an iso-osmolar test sugar solution (300 mmol/kg)
containing 0.5 g D-xylose, 1 g L-rhamnose, 0.2 g 3-O-
methyl-D-glucose and 5 g lactulose was prepared and
100 ml administered orally per subject. Gelatine capsules,
containing 50 mg pharmaceutical/food grade anatase TiO2
(Kronos® 1171; reported manufacturer’s d50 of 260 nm,
Fagron UK,) were manufactured by St Thomas’ Hospital
Pharmacy (London).
Conduct of the study
Following ethical approval (EC01/037) and informed con-
sent, eight healthy (self-reported) volunteers were recruited;
seven completed the study as blood could not be with-
drawn from the cannula of one subject. First, subjects were
provided with the permeability solution, 1 l of deionised
water and a 2 l urine bottle containing the preservative
thiomerasol. Subjects were asked not to consume any dairy
products from lunchtime the day before the test. At
7.00 am following an overnight fast, subjects emptied their
bladders and provided a baseline urine sample in 50 mluniversal tubes. They then ingested the 100 ml test sugar
solution and during the following two hours they were only
allowed to drink deionised water. Urine was collected
thereafter for 5 h in the 2 l urine bottles (i.e. until
12.00 pm).
At 9.00 am, a peripheral venous cannula was inserted
and a 5 ml baseline blood sample taken. Immediately
following this, subjects ingested two capsules each con-
taining 50 mg of pharmaceutical/food grade TiO2 (total
100 mg) with 250 ml water - one capsule was taken im-
mediately following the other. Blood samples were then
taken at baseline (0), at 30 min, and at 1, 1.5, 2, 3, 6, 8
and 10 h post TiO2 ingestion. Blood samples were
heparinised and analysed as described below.
Normal drinking water was provided throughout the
study and meals, free from added TiO2, were provided at
10.00 am (Breakfast: wholemeal toast with salted butter
and strawberry jam), 1.00 pm (Lunch: chicken and green
pepper stir fry with boiled rice, fresh fruit and a small
packet of plain crisps) and 4.00 pm (Mid-afternoon snack:
chocolate biscuit and/or fresh fruit). Tea and coffee with
milk and/or sugar were allowed as desired from 11 am
onwards.
Identification of TiO2 in blood by dark field microscopy
One drop of blood (~45 μl) from the syringe following
sampling (i.e. non-heparinised) was placed on a clean,
freshly opened glass slide. Superfrost plus slides were used
to allow cell adherence. The blood was spread thinly with
a clean slide to aid monolayer formation and a cover slip
was then sealed in place with nail vanish to prevent sam-
ple drying. The slide was examined by light microscopy
first at x 100 magnification and then x 400. Random areas
were visualised at x 400 using a dark-field condenser to
allow the titanium dioxide particles to be easily observed
as bright white discrete particles in contrast, for example,
to cell debris which was much less bright and less punc-
tate, and generally translucent. The estimation of particles
within each field was based on four reflectance grades;
namely 0, 1, 2 and 3, and the operator was blinded to
sample codes. A reflectance grade of 0 indicated 5 or less
particles/field, a grade of 1 showed 5 to 10 particles/field,
a grade of 2 showed 10 to 20 particles/field, and a grade of
3 indicated > 20 particles/field. Reflectance grades, rather
than absolute numbers, were used for rapid data acquisition
and because of the semi-quantitative nature of detection.
Visualisation of TiO2 particles by dark field microscopy
could only be carried out in five out of seven subjects due
to clotting of blood in two subjects.
Measurement of Ti by Inductively Coupled Plasma- Mass
Spectrometry (ICP-MS)
Aliquots of collected heparinised blood samples were acid
digested using sub-boiling nitric acid diluted with Milli-Q
Fig. 2 Reflectance micrographs of blood smears. Representative
examples of visualisation of blood smears at x 400 magnification by
dark field microscopy at baseline (t0), 2 h (t2) and 6 h (t6) following
ingestion of 100 mg TiO2 capsules, in two subjects. Examples of
particle-positive signals are indicated by the white arrows. A few
particles were present at t0, but were always below 5 particles
per field of analysis. Data for all five subjects are displayed and
summarised in Fig. 3
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concentrations were determined by High-Resolution ICP-
MS at the Department of Physical and Analytical Chemis-
try, University of Oviedo, Spain, using an Element 2
(Thermo Fisher Scientific, Waltham, MA, USA) working
at medium resolution (RS = 4000) to analyse the isotope
of 47Ti [15, 16]. For quantification, the method of isotope
dilution was applied [17]. Measurement of Ti was carried
for time points 0–10 h except in two subjects where
samples at 8 h in both, and 10 h in one, could not be
collected.
Statistics
The estimation of particle numbers present in blood
films and the levels of Ti following ingestion of TiO2
were assessed using a two-tailed paired t–test. The rela-
tionship between reflectance grades (i.e. TiO2 particles
within blood) and the levels of Ti measured by ICP-MS
was determined using a Spearman correlation test. For
all tests, significance was taken at p < 0.05.
Results and discussion
The seven subjects had normal gut permeability and
absorption characteristics of the different sugars based
upon their urinary excretion data (Fig. 1). Some of the
ingested TiO2 was absorbed directly into the blood
stream in its particulate form based upon dark field mi-
croscopy (Figs. 2 and 3a). Positive signals were assumed
to be TiO2 particles since no other sources of particles
were provided (i.e. the subjects only ingested TiO2 parti-
cles and the lunch provided had no particulate addi-
tives). As such, whilst occasional positive signals were
noted at baseline (i.e. bright discrete particles), observa-
tions always numbered less than 5 per field (i.e. scored
0; Figs. 2 and 3a). Significant increases in positive signals
were observed in the blood films from 2 h onwards
(Figs. 2 and 3a, p < 0.05). Dark field microscopy findings














Fig. 1 Intestinal permeability and absorption. Small molecule
permeability (black circles; lactulose:rhamnose excretion) and absorption
(black squares; rhamnose:3-O-methyl glucose excretion) ratios. The
reference ranges for permeability (dotted line) and absorption (dashed
line) are ratios of <0.05, and 0.132 – 0.258, respectivelytotal Ti within the same blood samples (Fig. 3b, c, t2-t10),
with both techniques demonstrating a peak of absorption
at 6 h post ingestion (Fig. 3a, b; p < 0.05). Indeed, there
was a positive correlation between reflectance grades and
total Ti levels (Fig. 3c, p = 0.0058 and r = 0.5803).
Our current findings substantiate those of Bockmann et
al., in which a comparable trial design demonstrated a simi-
lar pattern of titanium loading into the blood stream of hu-
man subjects following the ingestion of TiO2 [12].
However, we now show that these total Ti signals by ICP
can be reasonably attributed to the actual absorption of
whole particles (i.e. TiO2). Confirmation that the direct up-
take of particulates occurs early (Figs. 2 and 3a), and peaks
late (Fig. 3a), has some important implications for under-
standing oral particle exposure to humans. First, it confirms
that persistent particles (i.e. those that evade gut and cellu-
lar digestion) can be taken up systemically in man, confirm-
ing the results of many animal studies and models of
uptake [18–20]. Secondly, it provides further evidence to
agree with Bockmann’s observations that, in humans, a bi-
modal pattern of particle uptake occurs: it starts early (i.e.
visible by 2 h following ingestion) but peaks later (i.e. 6 h
following ingestion). If so, this pattern may be explained by
some absorption in the proximal small intestine (duode-
num/jejunum) [1, 7] with later Peyer’s patch uptake in the
more distal small intestine (ileum) [1]. Peyer’s patches are
















































Fig. 3 Absorption of TiO2 particles into the blood stream. a- Grading of
the frequency of discrete particulate reflectance in blood smears by dark
field microscopy following ingestion of 100 mg TiO2 capsules (n = 5
subjects). Data are plotted as mode (column) and individual grades
(closed circles). * p< 0.05 and **p< 0.01 vs time point 0, two-tailed
paired t test. b- Total Ti levels (ppb) measured by ICP-MS in the same
blood samples as above with two further subjects (total seven). Data are
represented as mean +/− SEM. *p< 0.05 and **p< 0.01 vs time point 0,
two-tailed paired t test. c- Correlation between reflectance grades and
total Ti levels in blood for the five complete subjects only. Pearson
correlation p= 0.0058 and r= 0.5803
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(M) cells that specifically and avidly capture small particles.
How such non-biological particles are then distributed is
not clear, although local cellular uptake of the particles may
occur (i.e. in mucosal antigen presenting cells [21]), with
the potential for translocation to the mesenteric lymph
nodes and then beyond, as well as distribution to other
organs as shown in animal studies. For the latter, blood-
borne transport must occur, as we confirm, although
whether the particles are transported within or outside of
immune cells requires confirmation.
The route of putative proximal absorption is less clear.
As noted earlier, the term persorption has been coined by-
and the phenomenon well described by- Volkeimer [7].
Additionally, the sporadic occurrence of small M-cell rich
areas throughout the small intestine [22] may also provide
ports of entry for particles, or the nano fraction of the
ingested particles could pass through regular epithelial cells
to underlying dendritic cells, as recently described [23]. It
was not our intention to size the absorbed TiO2 particles
and hence we did not measure the size distribution of the
TiO2 administered. Nevertheless, a recent publication in-
vestigating the same TiO2 particles quotes a primary par-
ticle size distribution of 88.9-200.6 nm (d10-d84) [24]
which is smaller than the stated manufacturer's d50 of 260
nm, perhaps because the latter also measured small ag-
glomerates during analysis. More importantly the particles
represent a ‘real life’ scenario of what humans can be ex-
posed to, either in food or pharmaceuticals, and clearly a
fraction of it will be nano-sized [11]. Further work will need
to confirm the proposed proximal intestinal uptake of parti-
cles, in humans, and the underlying mechanisms, but a
preference for penetration by the nano-sized fraction
should not be ruled out as this is seen in rodents [18, 19].
Finally, although the ingestion of 100 mg TiO2 exceeds
human intestinal exposure as a single dose, it falls within
daily limits [10] and higher dosing facilitates analytical de-
tection. Therefore, whilst absolute particle absorption may
be lower in the general population than observed here, the
percentage absorbed is likely to be higher. Indeed, Powell
and colleagues have estimated that adult humans
may absorb 1012 TiO2 particles/person/day [25]. Further
quantification work of titanium dioxide absorption at
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sizes is now needed.
The recent implementation of new software for single
particle ICP-MS analysis [26], advancements of hyphenated
techniques like field flow fractionation [27] and hydro-
dynamic chromatography [28] combined with ICP-MS and
the emergence of a triple quadrupole ICP-MS [29] should
all aid the development of quantitative techniques to help
assess human exposure to TiO2.
In summary, we show here that a portion of ingested
pharmaceutical and food grade TiO2, to which humans
are very frequently orally exposed, is directly absorbed,
as particles, into the blood stream of healthy volunteers.
The seemingly early absorption and late peak of uptake
point towards two distinct periods and perhaps routes of
uptake: one early in the proximal small intestine and one
late in the distal small intestine. Quantitative measure-
ments are now merited to estimate real human exposures.
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